Clinical Trial Update: Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing tofacitinib versus methotrexate for severe alopecia areata is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata
• Alopecia Totalis
• Alopecia Universalis

Drugs mentioned

• Trexall (Methotrexate)
• XELJANZ (tofacitinib)

Snippet

Sponsor: Hayat Abad Medical Complex, Peshawar | Conditions: Alopecia Areata, Alopecia Totalis (AT) | Phase 4 | Status: NOT_YET_RECRUITING